{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:53:57Z","timestamp":1759366437313,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.revmed.2007.09.040","type":"journal-article","created":{"date-parts":[[2007,10,26]],"date-time":"2007-10-26T05:58:26Z","timestamp":1193378306000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apport des \u00e9changes plasmatiques dans le traitement de la myasth\u00e9nie\u00a0: \u00e9tude de 11 cas"],"prefix":"10.1016","volume":"29","author":[{"given":"M.I.","family":"Miladi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Elleuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Triki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gargouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mhiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2007.09.040_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.transci.2006.06.008","article-title":"Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases","volume":"36","author":"Y\u00fccesan","year":"2007","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.revmed.2007.09.040_bib2","unstructured":"Oosterhuis HJ. Myasthenia gravis. In: Clinical neurology and neurosurgery. Churchill Livingstone. New York: Monographs 5;1984:156\u20138."},{"key":"10.1016\/j.revmed.2007.09.040_bib3","first-page":"1S30","article-title":"Place des immunoglobulines intraveineuses dans le traitement de la myasth\u00e9nie","volume":"151","author":"Gajdos","year":"2000","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.revmed.2007.09.040_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1212\/WNL.52.3.629","article-title":"Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis","volume":"52","author":"Qureshi","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.09.040_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0002-9343(75)90125-4","article-title":"Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations","volume":"58","author":"Genkins","year":"1975","journal-title":"Am J Med"},{"issue":"8000","key":"10.1016\/j.revmed.2007.09.040_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"Pinching","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2007.09.040_bib7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archneur.1984.04210080062015","article-title":"Plasma exchange in neurologic diseases","volume":"41","author":"Lisak","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1526-0968.2000.004004291.x","article-title":"The six years experience of plasmapheresis in patients with myasthenia gravis","volume":"4","author":"Chiu","year":"2000","journal-title":"Ther Apher"},{"key":"10.1016\/j.revmed.2007.09.040_bib9","first-page":"91","article-title":"Traitement de la myasth\u00e9nie","volume":"153","author":"Gajdos","year":"1997","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/jnnp.43.5.397","article-title":"Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy","volume":"43","author":"Carter","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2007.09.040_bib11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/thx.50.10.1080","article-title":"Comparative effects of plasma and pyridostigmine on respiratory muscle strength and breathing patterm in patients with myasthenia gravis","volume":"50","author":"Goti","year":"1995","journal-title":"Thorax"},{"issue":"S1","key":"10.1016\/j.revmed.2007.09.040_bib12","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/ana.410370707","article-title":"Myasthenia gravis: immunological mechanisms and immunotherapy","volume":"37","author":"Lewis","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1526-0968.2000.004004280.x","article-title":"Plasma exchange for treatment of myasthenia gravis: pathophysiologic basis and clinical experience","volume":"4","author":"Qureshi","year":"2000","journal-title":"Ther Apher"},{"key":"10.1016\/j.revmed.2007.09.040_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01706318","article-title":"Plasmapheresis: technique and complications","volume":"16","author":"Reimann","year":"1990","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.revmed.2007.09.040_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","article-title":"Treatment of myasthenia gravis by immunoadsorption of plasma","volume":"45","author":"Grob","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.09.040_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jca.1026","article-title":"Coagulation abnormalities in serial double-filtration plasmapheresis","volume":"16","author":"Yeh","year":"2001","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.revmed.2007.09.040_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(79)91492-2","article-title":"Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis","volume":"8140","author":"Behan","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2007.09.040_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1537-2995.1999.39399219285.x","article-title":"Frequency of immediate adverse effects associated with therapeutic apheresis","volume":"39","author":"McLeod","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2007.09.040_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1246-7820(02)00245-8","article-title":"Transfusional and therapeutic applications of apheresis techniques","volume":"9","author":"Giraud","year":"2002","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.revmed.2007.09.040_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.410350304","article-title":"Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease","volume":"35","author":"Thornton","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s004150070149","article-title":"Comparison between double filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis","volume":"247","author":"Yeh","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1526-0968.2000.004004275.x","article-title":"Therapeutic apheresis in myasthenia gravis","volume":"4","author":"Batocchi","year":"2000","journal-title":"Ther Apher"},{"key":"10.1016\/j.revmed.2007.09.040_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/BF01815277","article-title":"Complications of plasma exchange in patients with neurological diseases","volume":"68","author":"Henze","year":"1990","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.revmed.2007.09.040_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(79)90666-4","article-title":"Combined plasma exchange and immunosuppression in myasythenia gravis","volume":"8145","author":"Behan","year":"1979","journal-title":"The Lancet"},{"key":"10.1016\/j.revmed.2007.09.040_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1034\/j.1600-0404.2001.104002078.x","article-title":"Double filtration plasmapheresis in the treatment of myasthenic crisis \u2013 analysis of prognostic factors and efficacy","volume":"104","author":"Yeh","year":"2001","journal-title":"Acta Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0028-3886.15050","article-title":"Myasthenic crisis: clinical features, complications and mortality","volume":"53","author":"Murthy","year":"2005","journal-title":"Neurol India"},{"key":"10.1016\/j.revmed.2007.09.040_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1749-6632.1981.tb33768.x","article-title":"Response to plasmapheresis and immunosuppressive drug therapy in sixty myasthenia gravis patients","volume":"377","author":"Dau","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2007.09.040_bib29","first-page":"939","article-title":"Long-term effects of plasma exchange in myasthenia. Results of a randomized study","volume":"12","author":"Gajdos","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2007.09.040_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","volume":"24","author":"Juel","year":"2004","journal-title":"Semin Neurol"},{"key":"10.1016\/j.revmed.2007.09.040_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002275","article-title":"Plasma exchange for myasthenia gravis","author":"Gajdos","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.revmed.2007.09.040_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0404.1985.tb00902.x","article-title":"Plasma exchange in myasthenia gravis: clinical effect","volume":"72","author":"Thorlacius","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2007.09.040_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM198403223101206","article-title":"Therapeutic plasma exchange","volume":"310","author":"Shumak","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2007.09.040_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.44.6.469","article-title":"Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy","volume":"44","author":"Hawkey","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2007.09.040_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1600-0404.1986.tb07875.x","article-title":"Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies","volume":"74","author":"Thorlacius","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2007.09.040_bib36","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJM197711242972102","article-title":"Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis","volume":"297","author":"Dau","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2007.09.040_bib37","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/01.WNL.0000098887.24618.A0","article-title":"Treatment of autoimmune myasthenia gravis","volume":"61","author":"Richman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2007.09.040_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF02333667","article-title":"Myasthenia gravis treatment: twelve years experience on 110 patients","volume":"8","author":"Valli","year":"1987","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.revmed.2007.09.040_bib39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1098-1101(1997)12:4<165::AID-JCA2>3.0.CO;2-8","article-title":"Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group","volume":"12","author":"Rock","year":"1997","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.revmed.2007.09.040_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0955-3886(98)00022-8","article-title":"Plasmapheresis in myasthenia gravis. A survey","volume":"19","author":"Kuks","year":"1998","journal-title":"Transfus Sci"},{"key":"10.1016\/j.revmed.2007.09.040_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002277","article-title":"Intravenous immunoglobulin for myasthenia gravis","author":"Gajdos","year":"2003","journal-title":"Cochrane Database Syst Rev"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307008442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307008442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:24:19Z","timestamp":1759335859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866307008442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0248866307008442"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2007.09.040","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apport des \u00e9changes plasmatiques dans le traitement de la myasth\u00e9nie\u00a0: \u00e9tude de 11 cas","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2007.09.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}